# Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

> **NCT06824207** · — · ACTIVE_NOT_RECRUITING · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 2400 (estimated)

## Conditions studied

- Respiratory Syncytial Virus Immunization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06824207
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06824207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06824207, "Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06824207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*